Internal Medicine, Infectious Disease · Los Angeles, CA
NPI
1245597962
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8635 W 3rd St Ste 465w
Los Angeles, CA, 90048
Phone (310) 358-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
905 services
Medicare patients, 2024
270
Average age 71
Drug cost, 2024
$2.6M
1,327 prescriptions
Company payments, 2025
$193
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Foltz was code 99233 (hospital e&m - subsequent), 278 times for 120 patients. In total Christopher Foltz billed 905 services in 23 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 278 | 120 | $96.81 | $27K |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 126 | $65.35 | $16K |
| 99223 Hospital E&M - Initial | Facility | 118 | 111 | $141.22 | $17K |
| 99215 Office E&M - Established | Office | 65 | 43 | $139.73 | $9,083 |
| 36415 Venipuncture Blood Collection | Office | 52 | 35 | $8.65 | $450 |
| 99214 Office E&M - Established | Office | 50 | 35 | $102.70 | $5,135 |
| 99222 Hospital E&M - Initial | Facility | 37 | 34 | $107.75 | $3,987 |
By year: 2022 $89K for 1,031 services; 2023 $80K for 874 services; 2024 $81K for 905 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 52 | 35 | $8.65 | $450 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Foltz prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 206 prescriptions and refills. In total Christopher Foltz wrote 1,327 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 206 | 208 | 26 | $813K |
| Pifeltro Doravirine | 140 | 162 | 18 | $285K |
| Dovato Dolutegravir Sodium/Lamivudine | 103 | 111 | Under 11 | $338K |
| Tivicay Dolutegravir Sodium | 101 | 115 | 12 | $254K |
| Maraviroc Generic | 54 | 54 | Under 11 | $46K |
| Valacyclovir Valacyclovir Hcl | 45 | 62 | Under 11 | $2,358 |
| Descovy Emtricitabine/Tenofov Alafenam | 39 | 39 | Under 11 | $85K |
| Ampicillin Sodium Generic | 37 | 37 | Under 11 | $2,905 |
| Juluca Dolutegravir/Rilpivirine | 36 | 36 | Under 11 | $123K |
| Nevirapine Er Nevirapine | 34 | 50 | Under 11 | $11K |
| Acyclovir Generic | 32 | 38 | Under 11 | $601 |
| Emtricitabine Generic | 28 | 32 | Under 11 | $5,912 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 22 | 22 | Under 11 | $95K |
| Rosuvastatin Calcium Generic | 21 | 27 | Under 11 | $179 |
| Azithromycin Generic | 21 | 29 | Under 11 | $481 |
Brand drugs: 752 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Foltz $193 ($193 in general payments such as food, travel and fees) from 5 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $58.47.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.